Klick Health Builds Out Global Leadership Team and Offices
10.11.2022 12:03:00 EET | Business Wire | Press release
Building on its recent news about taking the company global, Klick Health today made several senior, global leadership team announcements as it builds out regional hubs in Asia-Pacific (APAC); Europe, the Middle East, and Africa (EMEA); and Latin America (LATAM).
Klick Health CEO Lori Grant welcomed agency veterans Jennifer Lambert and Roberta Raduan as its first global Managing Directors, and accomplished operations professionals Michael Becker, Shaun Chalk, and Catherine MacInnis to help lead its global operations and growth. The new senior executives will build on Klick’s strong people-first business model and supporting foundations, and work alongside seasoned Klick leaders Glen Webster, who has been named Executive Vice President, Global Operations; and Jennifer White, Global Head of Growth.
“We couldn’t be happier to welcome Jen Lambert, Roberta, Shaun, Mike, and Catherine to Klick–they are all proven leaders in their fields and have the global expertise required for a successful global rollout,” said Grant. “We’re also thrilled to announce Glen’s and Jen White’s new global roles–they have both contributed immeasurably to our industry-leading success and will be instrumental in helping us scale the Klick magic overseas.”
Jennifer Lambert – Managing Director, EMEA
A proven leader in growing agencies, managing client relations, and launching campaigns across the globe, Lambert joins Klick as Managing Director of EMEA. She spent the last decade at WPP, most recently as Chief Health Officer at Wunderman Thompson Health International, with many years serving as WPP lead for Team Pfizer, overseeing all the operations and talent across EMEA for the large network agency. Prior, she spent 15 years at Sudler & Hennessey, growing the agency’s presence across EMEA and Asia-Pacific. Lambert began her career at Ogilvy in New York after earning a biomedical degree at Rutgers University. She has worked across the spectrum of all therapeutic areas and has extensive expertise internationally within CRM, DTC, omnichannel, and brand defense/LTV strategy planning. Outside of work, Jennifer donates her time to helping create change in health, including working on pro-bono platforms with the United Nations, NGOs, and academia to help drive support for victims of sexual abuse and violence.
“I joined Klick because there is something really different here,” Lambert said. “I love the entrepreneurial spirit and incredible energy you get from a large, independent powerhouse like Klick, and I’m thrilled to be helping bring Klick’s end-to-end services to life sciences clients in Europe, the Middle East, and Africa and creating real healthcare change across the globe.”
Roberta “Beta” Raduan – Managing Director, LATAM
Based out of São Paulo, Brazil, Raduan brings to Klick her proven entrepreneurial track record building successful agencies and her long-standing relationships with both clients and top talent in Latin America. A digital native and seasoned marketing communications professional with a strategic understanding of brands and business opportunities in the digital, data, and communication arenas, Raduan has spent the last 25+ years helping global and local B2B, CPG, fintech, FMCG, and telco brands achieve transformational growth. Most recently, she was Managing Director of Havas CX Brasil, previously serving as Digital Managing Director of Havas Brasil. Raduan was also a co-founding Partner and Managing Director of several São Paulo agencies, including Versão Beta, Sinc, and Euro RSCG 4D (Havas).
“I am thrilled about launching Klick in Latin America and bringing its award-winning, people-first approach here,” said Raduan. “I was drawn to Klick’s unique culture and its obsession for identifying and hiring top talent. Klick’s commitment to keep evolving to exceed clients’ needs and make the world a better, healthier place really resonates with my heart and soul.”
Michael Becker – Chief Financial Officer, Klick Group
Becker joins as Klick Group CFO with invaluable global finance leadership in the life sciences industry. Formerly a Senior Vice President at Pharmaceutical Product Development (PPD), he led a team of more than 450 global finance professionals. During his tenure at the industry-leading contract research organisation, Becker played a primary role in a number of its key strategic initiatives, Becker previously served as PPD’s Executive Director of Operations and Executive Director of Internal Audit. Prior, he spent 12 years in public accounting at Deloitte & Touche, mainly in external audit roles.
“I’m very excited to join Klick Group as CFO and serve as a strategic business partner to its forward-thinking, world-class leaders,” Becker said. “What the Klick team has done over the past 25 years is truly remarkable and a testament to the culture of excellence here. I look forward to helping build on Klick’s existing strong foundations as we scale the business further to support our people, our clients, and the patients they serve.”
Shaun Chalk – Executive Vice President, Global Client Operations
Chalk joins Klick in the newly minted role of EVP of Global Client Operations, focused on enhancing strategic value to clients and creating compelling commercial narratives across the organisation, as it scales internationally. He brings 25+ years of marketing & communication, commercial, finance and operational experience to the role–the last eight years at WPP, most recently as Chief Commercial Officer at WPP Health & Wellness. Previously, he was Global CFO for McCann Worldgroup’s Commonwealth and a Director of Global Operations & Technology at Citigroup. He spent his early career at Wunderman, Y&R, and Ogilvy, where he worked in senior finance and commercial positions in both U.S. and worldwide groups. Chalk has an MBA and Accounting and Economics degrees.
“This is a very exciting time to be joining Klick, with the opportunity to contribute to its continued growth and success as it continues to expand globally,” said Chalk. “I look forward to embracing the Klickster culture, partnering with our teams to deliver on our clients’ goals and objectives, and ultimately helping to improve health outcomes for more patients around the world.”
Catherine MacInnis – General Counsel
As General Counsel, MacInnis is responsible for Klick’s risk and legal portfolio worldwide, with a focus on growth, compliance, insurance, and corporate governance. She leads all legal aspects of the company’s global expansion, including strategic decision-making, as well as all corporate/commercial, employment, immigration, and privacy matters related to the expansion. She has contributed to the annual World Bank report on business regulation (Doing Business) and presents frequently on risk management for professional services providers. Prior to joining Klick, MacInnis served as Associate General Counsel at publicly traded, design-driven technology firm IBI Group from its global headquarters in Toronto. There, she was key in managing the growth of its award-winning legal team as the company quickly scaled to 3,300 people with offices around the world. Earlier in her career, she spent four years in Commercial Litigation at Blaney McMurtry LLP, and three years as a securities & commercial litigator at Groia & Company.
MacInnis said, “I joined Klick because I have the phenomenal opportunity to work with Klick’s industry thought leaders on very cool projects, including global expansion, and I could not be more excited to help make the vision of our incredible team a reality.”
Glen Webster, Executive Vice President, Global Operations
For almost two decades, Webster has played a pivotal role in laying the strong foundation for Klick’s award-winning workplace culture and industry-leading business performance. He has consistently helped inoculate Klick against the status quo and think differently–establishing and piloting many internal operational capabilities over the years, including in-house Culture & Engagement, Recruiting, Marketing, Contracts, Tax, Strategic Alliances, and Performance Management, eventually evolving them into departments run by others. Webster began his career 30 years ago in management consulting, working at Deloitte Consulting, CGI, and Price Waterhouse, and serving a diverse set of clients, including Astra Pharma, Bank of Montreal, and Sony. He has strong entrepreneurial roots, started Canada's first online retail drugstore during the dot-com boom (and winding it up during the bust), and selling enterprise software to clients, like Goldman Sachs. He has also served as a part-time professor, teaching at post-secondary institutions, such as the MBA program at the Schulich School of Business at York University, before finally joining Klick in 2006.
“I’ve spent more than half of my career focused on Klick’s growth and am incredibly energised about helping lead the charge in this exciting new chapter of our company’s history,” said Webster. “Going global means access to brilliant new talent markets and making more client wishes come true as we share the Klick difference with the whole world!”
Jennifer White, Global Head of Growth
White has spent over 20 years working across multiple healthcare industry segments in the U.S. and abroad, most recently as an Executive Vice President of Growth at Klick. With her deep understanding of every facet of the commercialisation lifecycle of healthcare clients, White will continue to drive the operationalisation and scaling of Klick’s growth efforts in North America in her new role as Global Head of Growth. She will also help commercialise Klick’s new global marketing model for the life sciences industry, which is designed to drive efficiency and scalability of marketing initiatives around the world, and leverages the full suite of assets within the Klick ecosystem to provide an agile and insights-driven global marketing approach, while synergistically incorporating critical local and regional nuances. Prior to Klick, White served as the founding Chief Commercial Officer for Circulation, where she led the company’s commercial efforts from their pre-revenue phase through the close of their $10.5 million Series A round. Earlier in her career, she held executive leadership roles at both WebMD and Aptus Health.
“I am incredibly grateful to have the opportunity to heighten my work in healthcare and growth to help drive commercial success for Klick’s new global model,” White said. “I’m also excited about the plans our team has to disrupt and transform antiquated global marketing approaches with a forward-thinking, agile model that honors the unique needs of local markets, while creating global campaigns in an efficient and scalable manner.”
According to Klick Co-President Ari Schaefer, “We’re delighted with how our global expansion is developing and by the response we’ve been getting around the world. This is just the beginning–we will have more exciting news to share in the near future.”
About Klick Health
Klick Health is the world’s largest independent commercialisation partner for life sciences. For over 25 years, Klick has been laser-focused on developing, launching, and supporting life sciences brands to maximise their full market potential as a core commercialisation partner. Klick recently ranked #1 on Medical Marketing + Media (MM+M) magazine’s Agency 100 list for the fifth straight year and was named an MM+M Large Agency of the Year for both 2020 and 2021, marking 10 Agency of the Year industry awards in 11 years. Follow Klick Health on LinkedIn and for more information on joining Klick, go to careers.klick.com.
About Klick Group
The Klick Group of companies–Klick Health (including Klick Katalyst), Klick Media Group, Klick Applied Sciences (including Klick Labs), Klick Consulting, Klick Ventures, and Sensei Labs–is an ecosystem of brilliant talent collectively working to maximise their people’s and clients’ full potential. Established in 1997, Klick has teams across North America, with offices in New York, Philadelphia, and Toronto, and is opening global offices in Basel, Buenos Aires, London, Munich, Paris, Singapore, São Paulo, and Tokyo. Klick has consistently been named a Best Managed Company and Great Place to Work. In 2021, the company was recognised with 15 Best Workplace awards, including Best Workplaces for Women, Best Workplaces for Inclusion, Best Workplaces for Giving Back, Fast Company’s Best Workplaces for Innovators, and FORTUNE’s Best Workplaces for Millennials.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221027006033/en/
Contact information
Sheryl Steinberg, Senior Vice President, Communications
416-214-4977 ext. 2412 pr@klick.com
Marisa McWilliams, Senior Manager, Communications
862-335-8165 pr@klick.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202630.8.2026 00:54:00 EEST | Press release
Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon company, in strategic partnership with the Emirates Falconers’ Club, at ADNEC Centre Abu Dhabi. The exhibition runs until 6 September. The falcon, owned
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 01:40:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the total amount of blood in the body. Maintaining controlled hematocrit levels below 45% is the primary treatment goal in PV.1 “For patients living with PV, uncontrolled hematocrit can have serious consequences, including an elevated risk of life-threatening thrombotic events," said Andrew T. Kuykendall, M.D., VERIFY lead investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “Curre
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 12:00:00 EEST | Press release
Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely with healthcare authorities and other stakeholders to support timely access for people with Parkinson’s disease who continue to experience moderate to severe motor fluctuations despite current oral therapies. Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. Despite availab
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
